CrossCare Fibroid Care™
Understand your fibroids, compare every treatment option including non-surgical ones, and prepare your case for review by licensed specialists.
Coordinated global care
Explore coordinated healthcare, treatment, diagnostics, second opinions, travel support and specialist services through one secure CrossCare workflow.
Availability varies by hospital, country, specialist and eligibility. Every request is reviewed by a CrossCare coordinator before we approach a provider on your behalf.
Understand your fibroids, compare every treatment option including non-surgical ones, and prepare your case for review by licensed specialists.
Comprehensive health-screening programmes with suitable hospitals and diagnostic centres — including specialist review, travel planning and follow-up.
Independent specialist reviews of your diagnosis, imaging and treatment plan. Turnaround depends on specialist availability, case complexity and record completeness.
Medical-record and discharge-summary translation, prescription and visa-document translation, plus written and live interpretation. Language availability is confirmed per request.
Specialist video consultations, second-opinion reviews, pre-travel briefings and post-treatment follow-up. Some cases may still require physical examination or in-person treatment.
Coverage verification, pre-authorisation coordination, hospital quotation support and reimbursement-document coordination.
Coordinate hospital quotations, treatment deposits, payment schedules and funding information through one clear workflow.
Blood pressure, glucose, heart-rate, oxygen and recovery tracking. Device compatibility and data integration are assessed per programme.
Enquiry and eligibility pre-screening for oncology, rare-disease, cardiology, gene therapy and stem-cell research. Eligibility is determined by the research team.
CAR-T case intake, pathology upload, specialist eligibility review and provider matching. Eligibility depends on diagnosis, treatment history, clinical status and provider acceptance.
Bone marrow transplant, haematopoietic stem-cell transplant, regenerative-medicine enquiry and research programme referrals. Suitability and regulatory status vary by condition and country.